View Author
patient liver study treatment hepatitis hepatitis c level liver failure infection hepatic encephalopathy encephalopathy brosi therapy brain failure rabbit ribavirin hepatic genotype virus result ammonia fi brosis liver fi brosis glutamate response effect signi sample biopsy group count hepatology table hyperammonemia baseline concentration platelet hcv patients peginterferon monocyte cd 4+foxp treg activity change analysis model plasma disease blood hepatitis c virus number value cirrhosis placebo serum ficant liver biopsy control netherland increase jtk -652 interferon narlaprevir diabetes mellitus protein score ana 773 bilirubin trial receptor stage intrahepatic liver disease virological response peginterferon alfa platelet counts hepatitis c patients mutation 16+ fibrotest
10 Most Recent Publications
|
Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA
(Article)
Pas, S.D. Molenkamp, R. Schinkel, J. Rebers, S. Copra, C. Seven-Deniz, S. Thamke, D. Knegt, R.J. de Haagmans, B.L. Schutten, M. |
2013-01-01
|
|
Clinical implications of chronic hepatitis e virus infection in heart transplant recipients
(Article)
Koning, L. Pas, S.D. Man, R.A. de Balk, A.H.M.M. Knegt, R.J. de Kate, F.J.W. ten Osterhaus, A.D.M.E. Eijck, A.A. van der |
2013-01-01
|
|
Continuous interferon-α,2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients
(Article)
Roomer, R. Bergmann, J.F. Boonstra, A. Hansen, B.E. Haagmans, B.L. Kwadijk-De Gijsel, S. Vuuren, A.J. van Knegt, R.J. de Janssen, H.L.A. |
2012-06-05
|
|
IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-α sensitivity devoid from classical interferon-α side effects?
(Article)
Orlent, H. Knegt, R.J. de Janssen, H.L.A. |
2012-03-01
|
|
Randomised clinical trial: Escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C
(Article)
Knegt, R.J. de Bezemer, G. Gool, A.R. van Drenth, J.P.H. Hansen, B.E. Droogleever Fortuyn, H.A. Weegink, C.J. Hengeveld, M.W. Janssen, H.L.A. |
2011-12-01
|
|
Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C
(Article)
Roomer, R. Vuuren, A.J. van Schutten, M. Heijens, A. Janssen, H.L.A. Knegt, R.J. de |
2011-09-12
|
|
Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders
(Article)
Fransen van de Putte, D.E. Fischer, K. Knegt, R.J. de Posthouwer, D. Erpecum, K.J. van Mauser-Bunschoten E. |
2011-09-01
|
|
Randomised clinical trial: Anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV
(Article)
Bergmann, J.F. Bruijne, J. Rahimy, M. Appleman, J.R. Freddo, J.L. Janssen, H.L.A. Reesink, H.W. Hotho, D.M. Knegt, R.J. de Boonstra, A. Weegink, C.J. Vliet, A.A. Wetering, J. van de Fletcher, S.P. Bauman, L.A. |
2011-08-01
|
|
The response to TLR ligation of human CD16+CD14- monocytes is weakly modulated as a consequence of persistent infection with the hepatitis C virus
(Article)
Peng C. Liu, B. Knegt, R.J. de Janssen, H.L.A. Boonstra, A. |
2011-07-01
|
|
Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients
(Article)
Stibbe, K.J.M. Verveer, C. Francke, J. Hansen, B.E. Zondervan, P.E. Kuipers, E.J. Knegt, R.J. de Vuuren, A.J. van |
2011-07-01
|
